TP53 and neoplasm: It has been shown by DNA binding, transcriptional activation and tumor-suppressing assays that the incorporation of a second mutation into oncogenic p53, referred to as second-site suppressor mutation, can rescue the normal activity of p53 as described later in the text for the current hot-spot mutations.